The Investors for Opioid Accountability (IOA), which Mercy Investment Services co-founded, is receiving significant acclaim for its progress with drug manufacturers, distributors and retailers, as its opioid-related resolutions continue to earn strong support from shareholders, including a recent vote of more than 61 percent at Rite Aid.
The most rewarding progress has been companies’ willingness to work with investors, and many have agreed to comprehensive board oversight of opioid sales and distribution.
- Assertio, Cardinal Health, Endo and McKesson have posted policies on their public websites.
- Allergan, AmerisourceBergen and CVS Health are developing policies, which will be posted within the next few months.
- Three companies will meet with the IOA in January and February.
Of the companies engaged, only Walgreens Boots Alliance continued to fight the resolution. At its annual meeting on January 25, more than 60 percent of shareholders voted in favor of the resolution calling on the board to report on how it’s addressing risks from the opioid crisis. Mercy Investment Services will continue to work with Walgreens on its response to shareholders’ request.